(BUSINESS WIRE)--KYTHERA is a privately-held, multi-product company applying the tools of biotechnology to develop first-in-class prescription products solely for the aesthetic market. KYTHERA has a robust pipeline, with clinical programs in adipolysis (ATX-101), facial contouring (ATX-104) and pigmentation modulation (ATX-202) and multiple research programs.
